BCAL Diagnostics (ASX:BDX) Other Operating Expense : A$2.64 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Other Operating Expense?

BCAL Diagnostics's Other Operating Expense for the six months ended in Dec. 2023 was A$1.09 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$2.64 Mil.

BCAL Diagnostics's quarterly Other Operating Expense increased from Dec. 2022 (A$0.57 Mil) to Jun. 2023 (A$1.55 Mil) but then declined from Jun. 2023 (A$1.55 Mil) to Dec. 2023 (A$1.09 Mil).

BCAL Diagnostics's annual Other Operating Expense increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.98 Mil) and increased from Jun. 2022 (A$0.98 Mil) to Jun. 2023 (A$2.12 Mil).

BCAL Diagnostics Other Operating Expense Historical Data

The historical data trend for BCAL Diagnostics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Other Operating Expense Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Other Operating Expense

0.98

2.12

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial			0.35	0.63	0.57	1.55	1.09

BCAL Diagnostics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$2.64 Mil.

BCAL Diagnostics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.